0001209191-18-055803.txt : 20181019
0001209191-18-055803.hdr.sgml : 20181019
20181019203736
ACCESSION NUMBER: 0001209191-18-055803
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181018
FILED AS OF DATE: 20181019
DATE AS OF CHANGE: 20181019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Neff Thomas B
CENTRAL INDEX KEY: 0001623238
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36740
FILM NUMBER: 181131386
MAIL ADDRESS:
STREET 1: C/O FIBROGEN, INC.
STREET 2: 409 ILLINOIS ST.
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIBROGEN INC
CENTRAL INDEX KEY: 0000921299
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-978-1200
MAIL ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-10-18
0
0000921299
FIBROGEN INC
FGEN
0001623238
Neff Thomas B
C/O FIBROGEN, INC.
409 ILLINOIS ST.
SAN FRANCISCO
CA
94158
1
1
0
0
Chief Executive Officer
Common Stock
2018-10-18
4
M
0
10319
3.60
A
2710412
D
Common Stock
2018-10-18
4
S
0
13136
54.23
D
2697276
D
Common Stock
2018-10-18
4
S
0
5364
55.13
D
2691912
D
Common Stock
2018-10-18
4
S
0
400
55.90
D
2691512
D
Common Stock
2018-10-18
4
S
0
718
54.36
D
94076
I
By Family Partnership
Common Stock
2018-10-18
4
S
0
200
55.29
D
93876
I
By Family Partnership
Common Stock
2018-10-19
4
M
0
10319
3.60
A
2701831
D
Common Stock
2018-10-19
4
S
0
6100
52.96
D
2695731
D
Common Stock
2018-10-19
4
S
0
6300
53.74
D
2689431
D
Common Stock
2018-10-19
4
S
0
4700
54.78
D
2684731
D
Common Stock
2018-10-19
4
S
0
1800
55.57
D
2682931
D
Common Stock
2018-10-19
4
S
0
618
53.20
D
93258
I
By Family Partnership
Common Stock
2018-10-19
4
S
0
300
54.69
D
92958
I
By Family Partnership
Common Stock
19500
I
By Spouse
Common Stock
60946
I
See footnote
Stock Option (Right to Buy)
3.60
2018-10-18
4
M
0
10319
0.00
D
2019-03-11
Common Stock
10319
175423
D
Stock Option (Right to Buy)
3.60
2018-10-19
4
M
0
10319
0.00
D
2019-03-11
Common Stock
10319
165104
D
Shares sold pursuant to a 10b5-1 plan.
The shares were sold at prices ranging from $53.73 to $54.71. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $54.765 to $55.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $53.90 to $54.77. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $55.26 to $55.31. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $52.305 to $53.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $53.31 to $54.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $54.31 to $55.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $55.31 to $55.77. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $52.90 to $53.75. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $54.15 to $55.01. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares are held by BioGrowth Partners, LP. The reporting person is the sole general partner of BioGrowth Partners, LP and has sole voting and dispositive power over the shares held by BioGrowth Partners, LP.
Fully vested.
/s/ Dorothy Pacini, Attorney-in-fact
2018-10-19